On The Fly: Pre-market Movers
HIGHER: Alkermes (ALKS), up 15% after the FDA rescinded its refusal to file letter for the new drug application for depression drug ALKS 5461 following "productive interactions" with the company... Eldorado Resorts (ERI), up 15% after announcing that it entered into a definitive agreement to acquire Tropicana Entertainment's (TPCA) gaming and hotels business in a cash transaction that is valued at $1.85B... Loxo Oncology (LOXO), up 6% after Morgan Stanley analyst Matthew Harrison upgraded Loxo after competitor Blueprint Medicines (BPMC) provided initial data at the AACR meeting on its RET inhibitor BLU-667 that he believes was at the lower-end of Loxo investors' expectations... Dynavax (DVAX), up 14% after initial data from a Phase 1b/2 head and neck cancer trial that JPMorgan analyst Anupam Rama called a "homerun." UP AFTER EARNINGS: Bank of America (BAC), up fractionally. LOWER: WPP (WPP), down 4.4% after CEO Sir Martin Sorrell resigns... Allegiant Travel (ALGT), down 6% after being featured negatively in a report on 60 Minutes last night... Blueprint Medicines, down 8.5% after reporting data on its RET inhibitor BLU-667 at a cancer meeting.